Context Therapeutics Insider Trades

CNTX

Track insider trading activity from Context Therapeutics executives and directors. See which insiders are buying and selling CNTX stock.

Trades Last 12 Months

CNTX Price

All Insider Trades for Context Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Levit Alex C. Chief Legal Officer, Corp. Sec
Holding Value $554k 270,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$626k 270,000 shares
$2.32
$2.05
Minai Azary Jennifer Lynn Chief Financial Officer
Holding Value $564k 275,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$638k 275,000 shares
$2.32
$2.05
Chagin Karen Deborah Chief Medical Officer
Holding Value $595k 290,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$673k 290,000 shares
$2.32
$2.05
Lehr Martin A. Chief Executive Officer
Holding Value $1.67M 815,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 815,000 shares
$2.32
$2.05
Holding Value $253k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$2.05
Smith Karen L. Director
Holding Value $253k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$2.05
Pasternak Andy Director
Holding Value $285k 138,900 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$90.3k 138,900 shares
$0.65
$2.05
West Linda Director
Holding Value $253k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$2.05
Holding Value $253k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$2.05
Holding Value $253k 123,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$80.3k 123,500 shares
$0.65
$2.05
Minai Azary Jennifer Lynn Chief Financial Officer
Holding Value $164k 80,010 shares
Last Trade
Jun 06, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.6k 40,010 shares
$0.64
$2.05
Dansky Ullmann Claudio Chief Medical Officer
Holding Value $359k 174,960 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$142k 174,960 shares
$0.81
$2.05
Berman Richard J Director
Holding Value $103k 50,000 shares
Last Trade
Jun 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$98.5k 50,000 shares
$1.97
$2.05
Sahmoud Tarek Chief Medical Officer
Holding Value $20.5k 10,000 shares
Last Trade
Aug 16, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$19.5k 10,000 shares
$1.95
$2.05
Holding Value $16.4k 8,000 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.4k 8,000 shares
$2.05
$2.05
Holding Value $59.9k 29,223 shares
Last Trade
Feb 15, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$59.9k 29,223 shares
$2.05
$2.05

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up